University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...

Understand RA from early to advanced stages. Explore symptoms, treatments, and lifestyle tips to manage rheumatoid arthritis ...

Bilateral versus unilateral cases of chronic rhinosinusitis with nasal polyps have notable clinical and laboratory ...

CRSwNP affects up to 4% of the general population, with approximately 40% having uncontrolled disease. In Japan, about 200,000 people with chronic sinusitis are subject to surgery due to nasal polyps.

LONDON - GSK plc (LSE/NYSE: GSK) has announced the acceptance of regulatory filings in China and Japan for depemokimab, a new biologic treatment for asthma with type 2 inflammation and chronic ...

CRSwNP is a chronic inflammatory sinus disease, with 80% of patients showing evidence of the type 2 airway inflammation associated with more severe diseases and symptoms. Depemokimab is not currently ...

20 The phase III programme in CRSwNP includes two studies, ANCHOR-1 and ANCHOR-2. 2,3 Depemokimab is currently being evaluated in phase III trials for the treatment of other IL-5 mediated diseases, ...

Crohn's disease is part of a group of conditions known as inflammatory bowel diseases (IBDs). There are five main types of Crohn's disease, each with its own set of symptoms. Doctors define each ...